Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stocchi

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Journal of Bone Oncology|December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?O Annibali, M T Petrucci, D Santini, et al.
Neurology|May 9, 2007
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson diseaseA Di Fonzo, H F Chien, M Socal, et al.
Journal of Neurology|April 13, 2023
Gender differences in microRNA expression in levodopa-naive PD patientsA Vallelunga, T Iannitti, G Somma, et al.
Journal of Neurology|May 8, 2023
Correction to: Gender differences in microRNA expression in levodopa‑naive PD patientsA Vallelunga, T Iannitti, G Somma, et al.
Journal of Medical Genetics|November 8, 2005
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestorS Goldwurm, A Di Fonzo, E J Simons, et al.
Neurology|July 13, 2005
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypesV Bonifati, C F Rohé, G J Breedveld, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Journal of Bone Oncology|December 11, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?O Annibali, M T Petrucci, D Santini, et al.
Neurology|May 9, 2007
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson diseaseA Di Fonzo, H F Chien, M Socal, et al.
Journal of Neurology|April 13, 2023
Gender differences in microRNA expression in levodopa-naive PD patientsA Vallelunga, T Iannitti, G Somma, et al.
Journal of Neurology|May 8, 2023
Correction to: Gender differences in microRNA expression in levodopa‑naive PD patientsA Vallelunga, T Iannitti, G Somma, et al.
Journal of Medical Genetics|November 8, 2005
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestorS Goldwurm, A Di Fonzo, E J Simons, et al.
Neurology|July 13, 2005
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypesV Bonifati, C F Rohé, G J Breedveld, et al.
Pageof 14